Literature DB >> 28639385

Prevalence and predictors of anemia in hereditary hemorrhagic telangiectasia.

Raj S Kasthuri1, Megan Montifar2, Jeffrey Nelson3, Helen Kim3,4, Michael T Lawton5, Marie E Faughnan2,6.   

Abstract

Entities:  

Year:  2017        PMID： 28639385      PMCID： PMC5997494          DOI： 10.1002/ajh.24832

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  6 in total

1.  Hereditary haemorrhagic telangiectasia: a population-based study of prevalence and mortality in Danish patients.

Authors:  A D Kjeldsen; P Vase; A Green
Journal:  J Intern Med       Date:  1999-01       Impact factor: 8.989

2.  Iron deficiency, general health and fatigue: results from the Australian Longitudinal Study on Women's Health.

Authors:  A J Patterson; W J Brown; J R Powers; D C Roberts
Journal:  Qual Life Res       Date:  2000       Impact factor: 4.147

3.  Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome).

Authors:  C L Shovlin; A E Guttmacher; E Buscarini; M E Faughnan; R H Hyland; C J Westermann; A D Kjeldsen; H Plauchu
Journal:  Am J Med Genet       Date:  2000-03-06

4.  Prevalence of iron deficiency and health-related quality of life among female students.

Authors:  Marie-Ange Grondin; Marc Ruivard; Anne Perrève; Hélène Derumeaux-Burel; Isabelle Perthus; Julie Roblin; Fabrice Thiollières; Laurent Gerbaud
Journal:  J Am Coll Nutr       Date:  2008-04       Impact factor: 3.169

5.  International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia.

Authors:  M E Faughnan; V A Palda; G Garcia-Tsao; U W Geisthoff; J McDonald; D D Proctor; J Spears; D H Brown; E Buscarini; M S Chesnutt; V Cottin; A Ganguly; J R Gossage; A E Guttmacher; R H Hyland; S J Kennedy; J Korzenik; J J Mager; A P Ozanne; J F Piccirillo; D Picus; H Plauchu; M E M Porteous; R E Pyeritz; D A Ross; C Sabba; K Swanson; P Terry; M C Wallace; C J J Westermann; R I White; L H Young; R Zarrabeitia
Journal:  J Med Genet       Date:  2009-06-23       Impact factor: 6.318

6.  A systematic analysis of global anemia burden from 1990 to 2010.

Authors:  Nicholas J Kassebaum; Rashmi Jasrasaria; Mohsen Naghavi; Sarah K Wulf; Nicole Johns; Rafael Lozano; Mathilda Regan; David Weatherall; David P Chou; Thomas P Eisele; Seth R Flaxman; Rachel L Pullan; Simon J Brooker; Christopher J L Murray
Journal:  Blood       Date:  2013-12-02       Impact factor: 22.113
  6 in total
  7 in total

1.  Hereditary hemorrhagic telangiectasia (HHT): a practical guide to management.

Authors:  Adrienne M Hammill; Katie Wusik; Raj S Kasthuri
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2021-12-10

2.  Pazopanib may reduce bleeding in hereditary hemorrhagic telangiectasia.

Authors:  Marie E Faughnan; James R Gossage; Murali M Chakinala; S Paul Oh; Raj Kasthuri; Christopher C W Hughes; Justin P McWilliams; Joseph G Parambil; Nicholas Vozoris; Jill Donaldson; Gitanjali Paul; Pamela Berry; Dennis L Sprecher
Journal:  Angiogenesis       Date:  2018-09-06       Impact factor: 9.596

3.  Development and performance of a hereditary hemorrhagic telangiectasia-specific quality-of-life instrument.

Authors:  Raj S Kasthuri; Shruti Chaturvedi; Sonia Thomas; Nathan Vandergrift; Carla Bann; Nicole Schaefer; Marianne S Clancy; Reed Pyeritz; Keith R McCrae
Journal:  Blood Adv       Date:  2022-07-26

4.  Weekly epistaxis duration as an indicator of epistaxis severity in hereditary hemorrhagic telangiectasia-Preliminary results from a randomized controlled trial.

Authors:  Vincent Wu; John M Lee; Nicholas T Vozoris; Marie E Faughnan
Journal:  Laryngoscope Investig Otolaryngol       Date:  2021-04-08

5.  Genotype-Phenotype Correlations in Children with HHT.

Authors:  Alexandra Kilian; Giuseppe A Latino; Andrew J White; Dewi Clark; Murali M Chakinala; Felix Ratjen; Jamie McDonald; Kevin Whitehead; James R Gossage; Doris Lin; Katharine Henderson; Jeffrey Pollak; Justin P McWilliams; Helen Kim; Michael T Lawton; Marie E Faughnan
Journal:  J Clin Med       Date:  2020-08-22       Impact factor: 4.241

6.  Pazopanib for severe bleeding and transfusion-dependent anemia in hereditary hemorrhagic telangiectasia.

Authors:  Joseph G Parambil; James R Gossage; Keith R McCrae; Troy D Woodard; K V Narayanan Menon; Kasi L Timmerman; Douglas P Pederson; Dennis L Sprecher; Hanny Al-Samkari
Journal:  Angiogenesis       Date:  2021-07-22       Impact factor: 9.596

7.  An international, multicenter study of intravenous bevacizumab for bleeding in hereditary hemorrhagic telangiectasia: the InHIBIT-Bleed study.

Authors:  Hanny Al-Samkari; Raj S Kasthuri; Joseph G Parambil; Hasan A Albitar; Yahya A Almodallal; Carolina Vázquez; Marcelo M Serra; Sophie Dupuis-Girod; Craig B Wilsen; Justin P McWilliams; Evan H Fountain; James R Gossage; Clifford R Weiss; Muhammad A Latif; Assaf Issachar; Meir Mei-Zahav; Mary E Meek; Miles Conrad; Josanna Rodriguez-Lopez; David J Kuter; Vivek N Iyer
Journal:  Haematologica       Date:  2021-08-01       Impact factor: 9.941
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.